(Q34056132)

English

Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

circulatory system

1 reference

based on heuristic

inferred from title

author name string

Zeina A Habib

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Leonidas Tzogias

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Suzanne L Havstad

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Karen Wells

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

George Divine

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

David E Lanfear

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Jeffrey Tang

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Richard Krajenta

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Manel Pladevall

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

L Keoki Williams

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

1 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Pharmacoepidemiology and Drug Safety

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

437-447

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Rosiglitazone for type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Pioglitazone for type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Indications for propensity scores and review of their use in pharmacoepidemiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

An application of propensity score matching using claims data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Clinical outcomes and adherence to medications measured by claims data in patients with diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Thiazolidinediones

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Risk of cardiovascular events associated with selective COX-2 inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Liver enzyme monitoring in patients treated with troglitazone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

The hope and the hazards of using compliance data in randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Estimating causal effects from large data sets using propensity scores

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Discrepancies between meta-analyses and subsequent large randomized, controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

5 July 2018

Rosiglitazone: a thunderstorm from scarce and fragile data

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1722

21 January 2018

Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1722

21 January 2018

Thiazolidinediones and cardiovascular outcomes in older patients with diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

28 October 2018

A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

28 October 2018

Gender and risk of adverse outcomes in heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

28 October 2018

COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2919167

28 October 2018

Rosiglitazone: seeking a balanced perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/19235778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronary heart disease outcomes in patients receiving antidiabetic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/19235778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone and myocardial infarction: cause for concern or misleading meta-analysis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19235778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The rosiglitazone story--lessons from an FDA Advisory Committee meeting

1 reference

https://pubmed.ncbi.nlm.nih.gov/19235778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death

1 reference

https://pubmed.ncbi.nlm.nih.gov/19235778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19235778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19235778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19235778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Compliance assessment in drug trials: has there been improvement in two decades?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19235778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/PDS.1722

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34056132&oldid=1990487084"